| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MYBL2_0001800 | Exon-Exon | chr20:42315492-42328684 | chr20:43686852-43700044 | 672 nt | 0.5804 |
| hsa_MYBL2_0001900 | Exon-Exon | chr20:42315492-42331543 | chr20:43686852-43702903 | 1086 nt | 0.5902 |
| hsa_MYBL2_0002000 | Exon-Exon | chr20:42315492-42345122 | chr20:43686852-43716482 | 2219 nt | 0.5886 |
| hsa_MYBL2_0002200 | Exon-Exon | chr20:42320797-42331543 | chr20:43692157-43702903 | 865 nt | 0.5884 |
| hsa_MYBL2_0002300 | Exon-Exon | chr20:42328397-42345122 | chr20:43699757-43716482 | 1835 nt | 0.5896 |
| hsa_MYBL2_0002500 | Exon-Exon | chr20:42331130-42331543 | chr20:43702490-43702903 | 414 nt | 0.6063 |
| hsa_MYBL2_0002600 | Exon-Exon | chr20:42331130-42333998 | chr20:43702490-43705358 | 554 nt | 0.5975 |
| hsa_MYBL2_0002700 | Exon-Exon | chr20:42331130-42338702 | chr20:43702490-43710062 | 654 nt | 0.5933 |
| hsa_MYBL2_0002800 | Exon-Exon | chr20:42331130-42341746 | chr20:43702490-43713106 | 873 nt | 0.5876 |
| hsa_MYBL2_0002900 | Exon-Exon | chr20:42331130-42343923 | chr20:43702490-43715283 | 1023 nt | 0.5875 |
A study in human acute myeloid leukemia (AML) demonstrated that the circMYBL2 is crucial for FLT3-dependent leukemia progression, where it interacts with PTBP1 to increase mutant FLT3 kinase protein levels [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A study in humans demonstrated that the circMYBL2 is a circular RNA with expression restricted to venous blood samples, serving as a specific biomarker for body fluid identification [Yu et al. DOI:10.1016/j.fsigen.2025.103416].